Developmental and Epileptic Encephalopathy (DEE)

By Dovy Paukstys, Founder, Komori Care

This article is educational and is not medical advice. It does not diagnose, treat, prevent, or cure any condition. Komori is not a medical device, is not FDA-cleared, does not detect seizures, and is not intended for people with epilepsy. Talk with a neurologist or epileptologist about personal medical decisions. Households living with epilepsy should use clinically validated seizure-detection devices as directed by their care team.

DEE is a category, not one disease. Families hear it after a gene result, or after an EEG, and think it replaced the syndrome name. It didn't. It sits on top.

I'm not a neurologist. I don't have epilepsy. I read the 2017 ILAE classification paper, the ILAE encephalopathy page, and NINDS so this hub uses the official split. Developmental. Epileptic. Or both.

Three terms. People mash them.

ILAE's diagnostic site keeps them separate.

Developmental encephalopathy: cognitive, neurological, or psychiatric impairment from the cause itself. The gene. The malformation. The injury. Seizures may be there. The delay is not blamed on the spike-wave.

Epileptic encephalopathy: the epileptic activity is doing the damage. Frequent seizures or a furious EEG slow or reverse development beyond what the cause would do alone.

Developmental and epileptic encephalopathy, DEE: both. The cause hits development. The epilepsy hits it again.

NINDS's public page compresses it. DEE is a group of severe epilepsies with seizures that are often drug-resistant, plus encephalopathy, meaning significant delay or loss of skills.

The 2017 paper is the one that put "developmental and epileptic encephalopathy" into the official lexicon. They were tired of "symptomatic generalized epilepsy," a junk drawer that mixed static intellectual disability plus mild seizures with the kids whose EEGs were eating development alive.

If you can pull the two pieces apart, do. In a neonate you often can't. Same months. Same brain. ILAE says so.

Why the word "developmental" got added

Older language blamed the seizures for everything. Then genetics showed up.

Dravet is the example the 2017 paper uses. Kids slow or regress between 1 and 2 years, at a time the EEG is often not yet that busy. The SCN1A change is already doing developmental work. Later the epilepsy piles on. That's DEE, not "just EE."

Some genes do an encephalopathy even after the seizures settle. The paper names KCNQ2 and STXBP1 in that group. The epilepsy may quiet. The developmental cost can stay.

Some genes go both ways. Severe DEE in one person. A milder, self-limited epilepsy in another. SCN1A, SCN2A, SLC2A1, KCNQ2, KCNA2, CHD2. Finding the gene is not the same as knowing the outcome. The electroclinical picture still matters.

When a gene of major effect is known, clinicians often say the gene plus "encephalopathy." STXBP1 encephalopathy. KCNQ2 encephalopathy. That's more useful than "DEE unspecified."

The long-tail gene pages live on Rare Epilepsy Long Tail. This hub is the umbrella.

Syndromes ILAE parks under this roof

Not every DEE has a famous name. These do, on the ILAE encephalopathy page.

Newborns and infants: early-infantile DEE (the bucket that now includes Ohtahara and early myoclonic encephalopathy), epilepsy of infancy with migrating focal seizures, infantile epileptic spasms syndrome, Dravet syndrome.

Childhood: epilepsy with myoclonic-atonic seizures, Lennox-Gastaut syndrome, DEE-SWAS / EE-SWAS, FIRES, hemiconvulsion-hemiplegia-epilepsy.

Variable age: progressive myoclonus epilepsies, Rasmussen syndrome.

EE-SWAS is used when development was typical before the regression. DEE-SWAS when there was already impairment, then more loss when the sleep EEG lit up. Landau-Kleffner is the language-first subtype of EE-SWAS.

LGS, IESS, EMAtS, EIDEE, LKS each have their own hub in this series. Don't flatten them into one Google term.

This is not "delay plus a few seizures"

ILAE is picky here. A static developmental encephalopathy with epilepsy is a different sentence. The delay comes from the cause. The seizures are along for the ride and are not the main driver of the cognitive picture.

DEE means the epileptic activity is contributing, or both pieces are. That distinction changes what you try to treat and what you tell a family about "if we stop the spikes, will development move." Sometimes yes, some. Sometimes the gene already spent that money.

I'm not going to sell hope I can't source. The 2017 paper says reducing epileptic activity may have the potential to improve developmental consequences. "May." "Potential." A clinician applies that to one child.

Causes. Think in ILAE buckets.

The 2017 paper wants etiology at every step. Structural. Genetic. Infectious. Metabolic. Immune. Unknown.

DEEs live in all of those. A cortical malformation. A de novo ion-channel change. A treatable metabolic error. Hypoxic-ischemic injury. Sometimes more than one label at once. Tuberous sclerosis is structural and genetic. Both words are correct.

NINDS says about half of people with epilepsy never get a named cause. DEE workups find more than they used to. They still miss.

CDC's basics page: less than half of newly diagnosed epilepsy has a known cause. Same weather.

What evaluation looks like, without a protocol

History. Exam. EEG, often sleep and video. MRI. Metabolic labs when the age and exam say so. Genetic testing, often a panel or exome, when the MRI is unrevealing or the syndrome is one of the gene-heavy ones.

NINDS lists those tools on the general epilepsy page. None of them belong to a blog. None of them belong to a consumer device.

Households living with epilepsy should use clinically validated seizure-detection devices as directed by their care team. A wellness monitor does not diagnose a DEE. It does not detect seizures. It does not prevent SUDEP.

Treatment talk stays general

Seizures in this group are often drug-resistant. NINDS says that out loud. Medicines, dietary therapy, surgery, implanted neurostimulation. Choice depends on syndrome, cause, and age. Pyridoxine-responsive metabolic disease is a different conversation than LGS. I'm not dosing either.

The point of finding a cause is that sometimes the cause changes the plan. GLUT1 and the ketogenic diet. A focal lesion and surgery. A gene with a known drug to avoid. Those are epileptologist sentences.

FAQ

What does DEE mean?

Developmental and epileptic encephalopathy. ILAE's term for a severe epilepsy where the cause can impair development and the epileptic activity can impair it further. NINDS: drug-resistant seizures plus significant delay or loss of skills.

Is DEE the same as an epileptic encephalopathy?

No. EE means the epileptic activity is the driver. DE means the cause is the driver. DEE means both. In newborns the two are often impossible to separate.

Is DEE one diagnosis?

No. It's a class. LGS, IESS, Dravet, EIDEE, EMAtS, DEE-SWAS, and a long list of gene-named encephalopathies sit under it. Some people never get a tighter syndrome name.

Who diagnoses a DEE?

A physician. Usually a pediatric neurologist or epileptologist, with genetics in the mix when a gene is on the table. EEG and often MRI. No website assigns this label.

Sources

• ILAE / epilepsydiagnosis.org, Encephalopathy: https://www.epilepsydiagnosis.org/encephalopathy.html
• Scheffer et al., ILAE classification of the epilepsies, Epilepsia (2017): https://www.ilae.org/files/dmfile/ClassificationOfEpilepsies_Scheffer_et_al-2017-Epilepsia.pdf
• NINDS, Epilepsy and Seizures: https://www.ninds.nih.gov/health-information/disorders/epilepsy-and-seizures
• CDC, Epilepsy Basics: https://www.cdc.gov/epilepsy/about/index.html